Evidence map›Paper›PMID 28043765›Full record

ArticleOral oncology2017

Corrigendum to 'Effect of HPV on head and neck cancer patient survival, by region and tumor site: A comparison of 1362 cases across three continents' [Oral Oncol. 62 (2016) 20-27].

Gypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, Behnoush Abedi-Ardekani, Daniel C Beachler, David I Conway, Andrew F Olshan, Victor Wunsch-Filho, Tatiana N Toporcov, Wolfgang Ahrens and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oral oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Gypsyamber D'SouzaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: gdsouza2@jhu.edu.
Devasena AnantharamanGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Tarik GheitInfections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France.
Behnoush Abedi-ArdekaniGenetic Cancer Susceptibility Group, International Agency for Research on Cancer, Lyon, France.
Daniel C BeachlerDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
David I ConwaySchool of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, UK.
Andrew F OlshanDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Victor Wunsch-FilhoDepartment of Epidemiology, School of Public Health, Universidade de São Paulo, São Paulo, Brazil.
Tatiana N ToporcovDepartment of Epidemiology, School of Public Health, Universidade de São Paulo, São Paulo, Brazil.
Wolfgang AhrensLeibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany; Institute for Statistics, University Bremen, Bremen, Germany.
Kathy WisniewskiDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Franco MerlettiDepartment of Medical Sciences, University of Turin, Turin, Italy.
Stefania BocciaSection of Hygiene-Institute of Public Health, Faculty of Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.
Eloiza H TajaraDepartment of Molecular Biology, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, São Paulo, Brazil.
Jose P ZevallosDepartment of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
José Eduardo LeviVirology Lab, Tropical Medicine Institute, Universidade de São Paulo, São Paulo, Brazil.
Mark C WeisslerDepartment of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Sylvia WrightDepartment of Pathology, Queen Elizabeth University Hospital, Glasgow, UK.
Ghislaine SceloGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France.
Angela L MazulDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Massimo TommasinoInfections and Cancer Biology Group, International Agency for Research on Cancer, Lyon, France.
Gabriella CadoniHead and Neck Surgery Department, Institute of Otorhinolaryngology, Università Cattolica del Sacro Cuore, Fondazione Policlinico "A. Gemelli", Rome, Italy.
Paul BrennanGenetic Epidemiology Group, International Agency for Research on Cancer, Lyon, France. Electronic address: brennan@iarc.fr.

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
Gene Environment Interaction in Head and Neck CancerR01CA090731 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI OLSHAN, ANDREW · 2001 to 2005
$4.6M
Cancer Control Education ProgramT32CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa B Gilkey, Melissa A. Troester · 2017 to 2026
$3.7M
NCI NIH HHS R01 CA090731NCI NIH HHS T32 CA057726NIEHS NIH HHS P30 ES010126World Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28043765
PMCPMC5755376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.